Definium Therapeutics Ownership & Insider Activity - Benzinga

SPY761.11+0.15%QQQ704.88+0.07%BTC/USD80,528.90−0.30%DIA522.05+0.13%GLD366.33−0.08%TLT81.30−0.05%

Premium Services

Premium Services

Definium Therapeutics Inc

DFTXNASDAQ

Trade with Public

Trade with Public

$35.67

-0.33-0.92%

Last update: Oct 23, 4:00 PM

Overview News Earnings Forecast Events Price Targets Financials SentimentOwnershipCompare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Definium Therapeutics Ownership & Insider Activity - Benzinga

Definium Therapeutics Ownership & Insider Activity

Definium Therapeutics (DFTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

5

$2.3M total

Net Activity

Net Selling

Net Value (90d)

-$2.3M

Definium Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 25, 2026	Daniel Karlin	CHIEF MEDICAL OFFICER	SELL	10.853K	$36.57	$397K
Sep 25, 2026	Robert Barrow	CHIEF EXECUTIVE OFFICER	SELL	31.550K	$36.57	$1.2M
Sep 25, 2026	Matthew T Wiley	CHIEF COMMERCIAL OFFICER	SELL	3.097K	$36.57	$113K
Sep 25, 2026	Mark Sullivan	CHIEF LEGAL OFFICER	SELL	14.051K	$36.57	$514K
Sep 25, 2026	Brandi Roberts	CHIEF FINANCIAL OFFICER	SELL	3.377K	$36.57	$123K
Sep 2, 2026	Robert Barrow	CHIEF EXECUTIVE OFFICER	GRANT	20.977K	$37.94	$722K
Jun 25, 2026	Mark Sullivan	CHIEF LEGAL OFFICER	SELL	13.008K	$45.03	$586K
Jun 25, 2026	Brandi Roberts	CHIEF FINANCIAL OFFICER	SELL	3.013K	$45.03	$136K
Jun 25, 2026	Robert Barrow	CHIEF EXECUTIVE OFFICER	SELL	29.208K	$45.03	$1.3M
Jun 25, 2026	Dan Karlin	CHIEF MEDICAL OFFICER	SELL	10.035K	$45.03	$452K
Jun 25, 2026	Matthew T Wiley	CHIEF COMMERCIAL OFFICER	SELL	2.867K	$45.03	$129K